Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.2469
Oct 30 • 3:59 PM ET Dollar change-0.0262 Percentage change(-9.59%)
Aftermarket Close
0.2518
Aftermarket • 7:30 PM ET Dollar change+0.0049 Percentage change(1.98%)
Index
-
Market Cap
24.44M
Enterprise Value
1.85M
Income
-192.42M
Sales
294.72M
Book/sh
1.20
Cash/sh
0.25
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
3568
IPO
Dec 17, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
0.08
P/B
0.21
P/C
0.97
P/FCF
-
EV/EBITDA
-
EV/Sales
0.01
Quick Ratio
1.66
Current Ratio
1.66
Debt/Eq
0.22
LT Debt/Eq
0.14
Option/Short
Yes / Yes
EPS (ttm)
-1.96
EPS next Y
-0.27
EPS next Q
-0.11
EPS this Y
72.42%
EPS next Y
46.80%
EPS next 5Y
44.18%
EPS past 3/5Y
- -49.56%
Sales past 3/5Y
-9.90% 27.91%
EPS Y/Y TTM
-969.05%
Sales Y/Y TTM
-32.40%
EPS Q/Q
-41.93%
Sales Q/Q
-8.70%
Insider Own
6.51%
Insider Trans
0.00%
Inst Own
35.72%
Inst Trans
-8.73%
ROA
-64.67%
ROE
-92.44%
ROIC
-142.24%
Gross Margin
25.62%
Oper. Margin
-32.00%
Profit Margin
-65.29%
SMA20
-16.15%
SMA50
-28.56%
SMA200
-56.79%
Trades
Shs Outstand
98.86M
Shs Float
92.55M
52W High
1.16 -78.81%
52W Low
0.24 2.53%
Volatility
9.10% 8.83%
ATR (14)
0.03
RSI (14)
31.04
Beta
0.98
Rel Volume
2.40
Avg Volume
716.79K
Volume
1,717,530
Perf Week
-8.99%
Perf Month
-37.37%
Perf Quarter
-61.92%
Perf Half Y
-63.39%
Perf YTD
-71.87%
Perf Year
-76.49%
Perf 3Y
-95.89%
Perf 5Y
-97.55%
Perf 10Y
-
Prev Close
0.27
Price
0.25
Change %
-9.59%
Consensus
Buy
Avg. Price Target
$1.88
Implied Upside
+661.4%
Analysts6incl. previous ratings
Rating Distribution4 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 09, 2025Downgrade
BBTIG Research
Buy → Neutral
Feb 28, 2025Downgrade
DB logoDDeutsche Bank
Buy → Hold$5 → $2.85+1,054.3%
Aug 18, 2023Initiated
BBTIG Research
Buy$15+5,975.3%
Apr 21, 2023Initiated
CCantor Fitzgerald
Overweight$11+4,355.2%
Apr 19, 2022Initiated
DB logoDDeutsche Bank
Buy$11+4,355.2%
Jan 19, 2022Initiated
SF logoSStifel
Buy$14+5,570.3%
Dec 21, 2021Initiated
CCanaccord Genuity
Buy$13+5,165.3%
Dec 07, 2021Initiated
NNeedham
Buy$14+5,570.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tendler Ely DGeneral Counsel and SecretaryDec 15 '25Sale0.9116,85015,334258,795Dec 16 04:12 PM
Ely D TendlerDirectorDec 15 '25Proposed Sale0.9116,85015,382Dec 15 05:06 PM
DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
CEO & DirectorMr. Lee Bienstock
Treasurer & CFOMr. Norman Rosenberg
General CounselMr. Ely D. Tendler J.D.
Chief Information OfficerMr. Eiwe Lingefors
Vice President of Investor RelationsMr. Mike Cole